Endocrine-related adverse conditions induced by tyrosine kinase inhibitors
Simone De Leo, Matteo Trevisan, Claudia Moneta, Carla Colombo
Topics & Concepts
MedicineInternal medicineEndocrinologySunitinibNilotinibDasatinibAdverse effectThyroidSecondary hyperparathyroidismTyrosine kinaseParathyroid hormoneCancerCalciumReceptorNeuroendocrine Tumor Research AdvancesCancer Diagnosis and TreatmentLung Cancer Treatments and Mutations